MedPath
HSA Approval

APO-PROPRANOLOL TABLET 40 mg

SIN00041P

APO-PROPRANOLOL TABLET 40 mg

APO-PROPRANOLOL TABLET 40 mg

February 24, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C07AA05

propranolol

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

PROPRANOLOL HCl

40 mg

Propranolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-PROPRANOLOL TABLET 40 mg - HSA Approval | MedPath